Hangzhou Biotest Biotech Co.,Ltd.
SSE:688767.SS
32.14 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 87.887 | 170.623 | 121.622 | 128.073 | 135.627 | 129.872 | 100.163 | 108.39 | 103.686 | 144.48 | 232.744 | 506.652 | 1,017.268 | 314.827 | 345.464 | 665.954 | 491.831 | 221.578 | 150.34 | 414.845 | 78.609 |
| Cost of Revenue
| 47.305 | 62.823 | 63.795 | 65.813 | 74.823 | 38.21 | 56.26 | 65.922 | 59.198 | 161.991 | 103.806 | 219.974 | 399.005 | 147.297 | 133.246 | 413.395 | 187.377 | 82.812 | 46.049 | 89.324 | 45.756 |
| Gross Profit
| 40.582 | 107.8 | 57.826 | 62.259 | 60.804 | 91.661 | 43.903 | 42.468 | 44.488 | -17.512 | 128.938 | 286.678 | 618.263 | 167.53 | 212.217 | 252.559 | 304.454 | 138.766 | 104.291 | 325.521 | 32.853 |
| Gross Profit Ratio
| 0.462 | 0.632 | 0.475 | 0.486 | 0.448 | 0.706 | 0.438 | 0.392 | 0.429 | -0.121 | 0.554 | 0.566 | 0.608 | 0.532 | 0.614 | 0.379 | 0.619 | 0.626 | 0.694 | 0.785 | 0.418 |
| Reseach & Development Expenses
| 15.12 | 19.63 | 13.585 | 15.714 | 14.645 | 36.73 | 15.157 | 18.709 | 9.88 | 14.933 | 23.966 | 49.722 | 19.587 | 23.445 | 11.375 | 14.886 | 12.218 | 14.929 | 8.012 | 9.191 | 9.191 |
| General & Administrative Expenses
| 15.531 | -23.684 | 32.807 | 1.968 | 13.006 | -16.446 | 27.618 | -1.632 | 10.893 | -14.194 | 27.257 | -0.084 | 12.483 | -6.027 | 19.741 | 8.558 | 6.048 | -6.576 | 12.249 | 5.358 | 5.358 |
| Selling & Marketing Expenses
| 9.127 | -5.94 | 15.49 | 6.846 | 4.488 | 10.807 | 6.012 | 5.453 | 5.61 | 7.194 | 4.709 | 9.417 | 7.147 | -14.815 | 15.27 | 7.581 | 6.969 | 11.891 | 10.414 | 8.085 | 8.085 |
| SG&A
| 24.659 | -29.624 | 48.297 | 23.163 | 17.494 | -5.639 | 33.63 | 3.822 | 16.504 | -7.001 | 31.966 | 9.332 | 19.629 | -20.842 | 35.011 | 13.19 | 15.883 | 5.315 | 22.663 | 13.903 | 13.903 |
| Other Expenses
| -8.415 | 23.761 | -22.349 | -5.162 | 0.001 | -13.315 | 7.597 | 5.057 | 0.604 | 32.268 | -13.848 | 13.879 | 1.866 | 2.193 | -0.007 | 134.413 | -218.402 | 1.19 | 0.058 | -10.326 | -37.291 |
| Operating Expenses
| 31.364 | 13.767 | 39.533 | 44.039 | 32.946 | 36.68 | 34.256 | 38.079 | 26.988 | 40.201 | 42.084 | 72.934 | 41.082 | 26.395 | 39.42 | 134.413 | -218.402 | 33.653 | 28.443 | -10.326 | -37.291 |
| Operating Income
| 9.218 | 94.034 | 18.293 | 18.22 | 44.535 | 25.73 | 25.798 | 51.339 | 13.957 | -126.547 | -134.931 | 294.188 | 582.915 | 130.235 | 175.886 | 386.972 | 273.43 | 90.077 | 66.492 | 315.195 | 41.318 |
| Operating Income Ratio
| 0.105 | 0.551 | 0.15 | 0.142 | 0.328 | 0.198 | 0.258 | 0.474 | 0.135 | -0.876 | -0.58 | 0.581 | 0.573 | 0.414 | 0.509 | 0.581 | 0.556 | 0.407 | 0.442 | 0.76 | 0.526 |
| Total Other Income Expenses Net
| 0.248 | 1.411 | 0.17 | 0.281 | 0.001 | -13.315 | 7.597 | 5.057 | -0.286 | -6.757 | -0.039 | -3.928 | -1.722 | 2.193 | -0.007 | -0.083 | 0.001 | 1.19 | 0.058 | -0.022 | 0.018 |
| Income Before Tax
| 9.467 | 95.445 | 18.464 | 36.825 | 44.537 | 12.415 | 33.395 | 56.396 | 13.671 | -133.304 | 163.748 | 290.26 | 581.193 | 132.428 | 175.88 | 386.889 | 273.43 | 91.268 | 66.55 | 315.173 | 41.336 |
| Income Before Tax Ratio
| 0.108 | 0.559 | 0.152 | 0.288 | 0.328 | 0.096 | 0.333 | 0.52 | 0.132 | -0.923 | 0.704 | 0.573 | 0.571 | 0.421 | 0.509 | 0.581 | 0.556 | 0.412 | 0.443 | 0.76 | 0.526 |
| Income Tax Expense
| 1.815 | 15.309 | 2.087 | 5.746 | 5.002 | -2.824 | 4.297 | 6.935 | 2.169 | -21.461 | 23.695 | 38.473 | 87.605 | 16.329 | 25.386 | 261.964 | -178.125 | 12.794 | 12.949 | 85.257 | -31.887 |
| Net Income
| 8.732 | 80.304 | 17.037 | 32.544 | 39.631 | 15.078 | 29.925 | 49.703 | 11.899 | -111.843 | 139.82 | 252.438 | 492.529 | 114.48 | 150.38 | 335.577 | 233.154 | 78.934 | 53.721 | 266.56 | 35.932 |
| Net Income Ratio
| 0.099 | 0.471 | 0.14 | 0.254 | 0.292 | 0.116 | 0.299 | 0.459 | 0.115 | -0.774 | 0.601 | 0.498 | 0.484 | 0.364 | 0.435 | 0.504 | 0.474 | 0.356 | 0.357 | 0.643 | 0.457 |
| EPS
| 0.08 | 0.768 | 0.16 | 0.31 | 0.38 | 0.18 | 0.28 | 0.47 | 0.11 | -1.05 | 1.31 | 2.37 | 4.62 | 1.07 | 1.41 | 3.15 | 2.91 | 0.74 | 0.5 | 2.5 | 0.45 |
| EPS Diluted
| 0.08 | 0.768 | 0.16 | 0.31 | 0.38 | 0.18 | 0.28 | 0.47 | 0.11 | -1.05 | 1.31 | 2.37 | 4.62 | 1.07 | 1.41 | 3.15 | 2.91 | 0.74 | 0.5 | 2.5 | 0.45 |
| EBITDA
| -2.112 | 95.446 | 18.294 | 44.954 | 27.858 | 20.403 | -37.766 | 63.643 | 25.279 | -126.47 | 6.235 | 295.286 | 577.181 | 132.532 | 176.187 | 394.883 | 274.691 | 91.364 | 66.492 | 278.22 | 177.376 |
| EBITDA Ratio
| -0.024 | 0.559 | 0.15 | 0.351 | 0.205 | 0.157 | -0.377 | 0.587 | 0.244 | -0.875 | 0.027 | 0.583 | 0.567 | 0.421 | 0.51 | 0.593 | 0.559 | 0.412 | 0.442 | 0.671 | 2.256 |